IMB's latest news, explainers and more

 


Developing venom-based epilepsy drugs using lab-grown organs

Read more

Get the latest research to your inbox

Subscribe
 

  • Congratulations to IMB’s Dr Markus Muttenthaler who received the Miklós Bodanszky Award for his outstanding contributions to peptide science. 
  • Thanks to a $1.3 million state government research grant, IMB’s Dr Nathan Palpant has partnered with Professor John Fraser at The Prince Charles Hospital to develop next generation medical treatments to tackle heart disease, which claims the life of one Australian every 12 minutes.
  • Paralympian Chris Bond was 19 when a severe bacterial infection in his bowel spread through his body and sent him into septic shock. Today, on World Sepsis Day (13 September), Chris is working with IMB's Community for Open Antimicrobial Drug Discovery (CO-ADD) to bring attention to the multidrug-resistant bacteria that nearly took his life.
  • Inflazome Ltd, a company founded on research from The University of Queensland (UQ) and Trinity College Dublin, has closed a Series A financing round of up to €15 million (A$22 million).
  • IMB’s Mathilde Desselle has won the Queensland Women in Technology (WiT) InfoTech Professional Award for her leadership of biomedical research programs and facilities in the fields of genomics, bioinformatics and drug discovery.
  • IMB research could lead to a new treatment for Parkinson’s disease, with future potential applications to nearly 50 other disorders.
  • Researchers from IMB and Imperial College London have developed a method to distinguish viral and bacterial infections in children, which will save lives and reduce antibiotic use.
  • IMB researcher Professor Kirill Alexandrov has received funding from the Bill & Melinda Gates Foundation to develop a cheap, portable biosensor to detect a range of infectious diseases, including Dengue fever and Zika virus.
  • IMB spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.

Pages

Strawberry DNA extraction activity

Extract and view DNA from a strawberry using common household ingredients.

Get started

 

The Edge: Infection

The latest research and discovery

We are tackling the problem of drug-resistant bacteria through developing new diagnostics and treatments, and by empowering the community with knowledge on how to fight back against the threat of superbugs.

 View the latest issue
 Download magazine

Subscribe to our newsletter

Get the latest research straight to your inbox. 
Stay up-to-date as we answer questions about hot topics, and share the latest news at IMB, Australia’s #1 research institute.

Subscribe

General enquiries

  +61 7 3346 2222
  imb@imb.uq.edu.au

Media enquiries

IMB fully supports UQ's Reconciliation Action Plan and is implementing actions within our institute.

Support us

Donate to research
100% of donations go to the cause